丙型肝炎病毒NS5A基因在昆虫细胞中的表达及其分布研究

应用PCR方法从含有丙肝病毒全部非结构蛋白基因的质粒pBAC25中扩增出全长的NS5A基因DNA片段（约1.34kb),PCR扩增NS5A基因片段克隆到转移载体plueBacHisA中。重组转移质粒pBlueBacHis5ADNA与野生型杆状病（AcNPV)DNA共转染SF-9昆虫细胞,通过空斑纯化获得带有NS5A基因的重组病AcNS5A,对重组病毒基因组DNA进行酶切和PCR鉴定,证实HCV NS5A基因已插入重组病毒基因组中,AcNS5A感染SF-9细胞后,在细胞中表达出一条64kD的蛋白,用Western-blot分析,结果表明这种蛋白与抗HVCHS5A特异性抗体发生强烈反应,说明NS5A基因已在细胞中得到表达,应用免疫荧光技术与免疫组化技术进一步研究NS5A蛋白在昆虫细胞中不同时间的表达情况及其分布,结果表明,NS5A蛋白在AcNS5A重组病毒感染细胞24h后主要分布在细胞质膜上,而在48h后则同时分布于细胞质膜和细胞核内,在72h则完全布满整个细胞,我们认为NS5A蛋白定位于质膜和细胞核中,暗示着在病毒复制过程中NS5A蛋白可能参与病毒RNA在质膜上复制和细胞基因表达的调控。     

H5N1亚型禽流感病毒NS1基因在昆虫细胞中的表达

将H5N1亚型禽流感病毒（AIV）NS1基因插入到杆状病毒转移载体pFastBac1中,获得重组转移载体pFastBac1- NS1。将pFastBac1- NS1转化到DH10Bac感受态细胞中,筛选到重组转座子rBacmid-NS1。在脂质体转染试剂介导下将rBacmid-NS1转染对数生长期的Sf9昆虫细胞获得重组杆状病毒rBV-NS1。rBV-NS1感染Sf9细胞后,通过SDS-PAGE、Western blot和ELISA分析表明：获得了分子量为26ku的特异性NS1蛋白;并且该蛋白可与H5N1 AIV攻毒鸭的血清发生特异性免疫反应,而不能与H5N1AIV灭活疫苗免疫鸭的血清发生反应。试验结果表明：NS1在Sf9昆虫细胞中获得了高效表达,具有与天然蛋白相似的免疫活性,并可以作为区分免疫及自然感染个体的鉴别诊断抗原。本实验为建立禽流感病毒自然感染家禽与禽流感灭活苗免疫家禽的鉴别诊断方法奠定基础。     

丙型肝炎病毒NS5A蛋白对Huh7细胞周期的影响

应用PCR技术从含有丙型肝炎病毒（HCV）全长开放阅读框的质粒pBRTM／HCV1～3011中获得NS5A全长基因片段,利用基因重组技术将其克隆至真核表达载体pcDNA3．1（-）中。通过酶切、PCR及测序鉴定证实,NS5A基因已正确插入到pcDNA3．1（-）中。再利用脂质体介导转染Huh7细胞,30h后收获细胞,经Western blot验证,证实HCV的NS5A基因在Huh7细胞中已经获得表达。在培养条件完全一致的条件下,表达NS5A基因的Huh7细胞与pcDNA3．1（-）转染的细胞在转染30h后被收集起来,乙醇固定,PI染色后利用流式细胞仪检测细胞周期变化。G0／G1期由60．6％下降到49．7％,S期由23．9％上升到32．7％,而转染pcDNA3．1（-）细胞的细胞周期与正常的Huh7细胞则差别不大。从而证明HCV NS5A蛋白对Huh7细胞周期具有调节作用。     

HCV NS5A基因表达及其在血清学检测中的应用评估

Full-length NS5A gene of the hepatitis C virus was amplified by PCR using plasmid pBAC25 containing HCV nonstructural gene as template. The amplified fragment (about 1.34 kb) was cloned into plasmid pQE32, and the recombinant plasmid pQENS5A was expressed in JM109 strain. The NS5A protein was purified by NiSO4 metal chelating resin, and characterized by Western-blot. Its antigenecity was determined by ELISA. The positive detection rate of anti-NS5A was 75% (69/92) in ninety-two clinic sera. The positive rate of anti-NS5A was 82.5% (33/40) in fourty positive standand sera, and the negative rate of anti-NS5A was 100% (40/40) in fourty negative standand sera. The results showed that the Full-length NS5A proteinn had the higher sensitivity and specificity in the detection of HCV antibody in sera, we suggested that NS5A protein was a useful antigen for blood screening.     

HCV NS5A基因表达及其在血清学检测中的应用评估

人丙型肝炎病毒 (ＨＣＶ)感染可引起丙型肝炎、肝硬化和肝细胞癌[1] 。丙型肝炎病毒是单股正链ＲＮＡ病毒 ,基因组约长 9.5ｋｂ ,仅有一个开放阅读框 ,编码一个大的聚蛋白前体 ,由宿主蛋白酶和病毒编码的蛋白酶加工成多个成熟蛋白。非结构蛋白ＮＳ5Ａ分子量为 56ｋＤ/ 58ｋＤ。目前对ＮＳ5Ａ蛋白的功能尚不清楚 ,ＮＳ5Ａ蛋白可降低干扰素治疗效果[2 ] ;ＮＳ5Ａ蛋白含核定位序列 ,因此人们推测它在ＨＣＶＲＮＡ复制过程中可能起一定的作用[3～ 4 ] 。本研究在大肠杆菌中表达全长ＮＳ5Ａ蛋白 ,提纯后ＮＳ5Ａ蛋白能与大多数丙肝阳性血清起强烈…     

丙型肝炎病毒NS5区的研究及其临床意义

NS5区是丙型肝炎病毒基因组中最长的亚基因组片段,它可进一步分为NS5A和NS5B区。NS5基因及其所编码的蛋白在丙型肝炎病毒的基因分型、病毒检测及临床抗病毒治疗等方面具有重要的意义。本文就NS5区的特点以及以上几方面的应用加以阐述。     

庚型肝炎病毒NS3蛋白在昆虫细胞中的表达

庚型肝炎病毒(HGV)/GB病毒C(GBV-C)疑似引起人类庚型肝炎[1～3].HGV和GBV-C为同一病毒的两个不同分离株,本文将其称为GBV-C/HGV.GBV-C/HGV属黄病毒科,为单股正链RNA病毒,全长约9.4kb.基因组中仅含有一个单一开放阅读框,编码E1、E2结构蛋白和NS2、NS3、NS4及NS5非结构蛋白.GBV-C/HGV的NS3蛋白具备丝氨酸蛋白酶活性和解旋酶活性[3],在NS3蛋白中还存在线性抗原表位[4],因此,NS3蛋白是GBV-C/HGV的重要功能蛋白.     

丙型肝炎病毒Core与NS3基因的不同融合方式及其表达

丙型肝炎病毒(简称ＨＣＶ)是危害人类健康的传染性疾病,预防该病的传播主要借助于ＨＣＶ血清学诊断来筛选献血员和检测临床标本。从国内外已分离到的ＨＣＶ株得知,ＨＣＶ核心蛋白(Ｃｏｒｅ)和非结构蛋白ＮＳ3含有较强的优势抗原表位,其相应的抗体出现早,阳性率高,已成为目前第二、第三代ＨＣＶ免疫诊断试剂的重要成份[1,2]。通常Ｃｏｒｅ蛋白和ＮＳ3蛋白分别用基因工程方法表达,然后作为固定化抗原,检测人体内ＨＣＶ的抗体。我们对Ｃｏｒｅ和ＮＳ3的两种不同组合方式及其表达的研究,对于发展新的ＨＣＶ诊断试剂很有帮助,现将结果报道如下。1…     

Correlation between NS5A Dimerization and Hepatitis C Virus Replication

Hepatitis C virus (HCV) is the main agent of acute and chronic liver diseases leading to cirrhosis and hepatocellular carcinoma. The current standard therapy has limited efficacy and serious side effects. Thus, the development of alternate therapies is of tremendous importance. HCV NS5A (nonstructural 5A protein) is a pleiotropic protein with key roles in HCV replication and cellular signaling pathways. Here we demonstrate that NS5A dimerization occurs through Domain I (amino acids 1-240). This interaction is not mediated by nucleic acids because benzonase, RNase, and DNase treatments do not prevent NS5A-NS5A interactions. Importantly, DTT abrogates NS5A-NS5A interactions but does not affect NS5A-cyclophilin A interactions. Other reducing agents such as tris(2-carboxyethyl)phosphine and 2-mercaptoethanol also abrogate NS5A-NS5A interactions, implying that disulfide bridges may play a role in this interaction. Cyclophilin inhibitors, cyclosporine A, and alisporivir and NS5A inhibitor BMS-790052 do not block NS5A dimerization, suggesting that their antiviral effects do not involve the disruption of NS5A-NS5A interactions. Four cysteines, Cys-39, Cys-57, Cys-59, and Cys-80, are critical for dimerization. Interestingly, the four cysteines have been proposed to form a zinc-binding motif. Supporting this notion, NS5A dimerization is greatly facilitated by Zn(2+) but not by Mg(2+) or Mn(2+). Importantly, the four cysteines are vital not only for viral replication but also critical for NS5A binding to RNA, revealing a correlation between NS5A dimerization, RNA binding, and HCV replication. Altogether our data suggest that NS5A-NS5A dimerization and/or multimerization could represent a novel target for the development of HCV therapies.     

庚型肝炎病毒NS5区蛋白鼠单克隆抗体的制备

庚型病毒性肝炎是近年来世界上才确认的一种新型肝炎［１～３］。庚型肝炎病毒（ＨＧＶ）呈世界性分布,经血液传播为主,也可母婴传播。ＨＧＶ容易形成持续性感染,类似ＨＩＶ和ＨＣＶ。据粗略估计,我国大约有１００万～１０００万ＨＧＶ携带者。因此,ＨＧＶ已成为继乙...     

Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication

Hepatitis C virus (HCV) is a positive-strand RNA virus that frequently causes persistent infection associated with severe liver disease. HCV nonstructural protein 5A (NS5A) is essential for viral replication. Here, the kinase Raf-1 was identified as a novel cellular binding partner of NS5A, binding to the C-terminal domain of NS5A. Raf-1 colocalizes with NS5A in the HCV replication complex. The interaction of NS5A with Raf-1 results in increased Raf-1 phosphorylation at serine 338. Integrity of Raf-1 is crucial for HCV replication: inhibition of Raf-1 by the small-molecule inhibitor BAY43-9006 or downregulation of Raf-1 by siRNA attenuates viral replication.     

Hepatitis C Virus NS5A Inhibits Mixed Lineage Kinase 3 to Block Apoptosis

Hepatitis C virus (HCV) infection results in the activation of numerous stress responses including oxidative stress, with the potential to induce an apoptotic state. Previously we have shown that HCV attenuates the stress-induced, p38MAPK-mediated up-regulation of the K⁺ channel Kv2.1, to maintain the survival of infected cells in the face of cellular stress. We demonstrated that this effect was mediated by HCV non-structural 5A (NS5A) protein, which impaired p38MAPK activity through a polyproline motif-dependent interaction, resulting in reduction of phosphorylation activation of Kv2.1. In this study, we investigated the host cell proteins targeted by NS5A to mediate Kv2.1 inhibition. We screened a phage-display library expressing the entire complement of human SH3 domains for novel NS5A-host cell interactions. This analysis identified mixed lineage kinase 3 (MLK3) as a putative NS5A interacting partner. MLK3 is a serine/threonine protein kinase that is a member of the MAPK kinase kinase (MAP3K) family and activates p38MAPK. An NS5A-MLK3 interaction was confirmed by co-immunoprecipitation and Western blot analysis. We further demonstrate a novel role of MLK3 in the modulation of Kv2.1 activity, whereby MLK3 overexpression leads to the up-regulation of channel activity. Accordingly, coexpression of NS5A suppressed this stimulation. Additionally we demonstrate that overexpression of MLK3 induced apoptosis, which was also counteracted by NS5A. We conclude that NS5A targets MLK3 with multiple downstream consequences for both apoptosis and K⁺ homeostasis.     

重组HCV NS5区蛋白抗原在丙型肝炎检测中的应用

对ＨＣＶ ＮＳ５区部分基因进行了克隆表达,获得优质ＮＳ５区蛋白抗原。通过对不同人群抗－ＮＳ５检测表明,随访３年和６年的输血后丙肝病例抗－ＮＳ５阳性率分别为７０．５％和８０．９％,随访８年和１１年慢性丙肝病例分别为５０．７％和８２．４％。一般人群阳性率仅为１．７％,正常献血员中未检出阳性。